trimetazidine has been researched along with Kidney Diseases in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.55) | 18.2507 |
| 2000's | 7 (31.82) | 29.6817 |
| 2010's | 8 (36.36) | 24.3611 |
| 2020's | 6 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Bagang, N; Gupta, K; Mehra, K; Pandey, S; Singh, G | 1 |
| Abdallah, HA; Aboulhoda, BE; Al Dreny, BA; Alghamdi, MA; Ali, IH; Elwi, HM; Hassan, FE; Khalifa, MM; Matter, LM; Morsy, SA; Selmy, A | 1 |
| Chen, J; He, P; He, W; Lian, X; Liu, Y; Tan, N; Zhan, H | 1 |
| Fu, N; Li, W; Men, X; Yang, S; Zhang, P; Zhang, X | 1 |
| Fu, H; Fu, N; Fu, X; Li, W; Liu, X; Yang, S; Zeng, Z; Zhang, H; Zhang, J; Zhang, P; Zhang, X | 1 |
| Bulacio, RP; Hazelhoff, MH; Torres, AM | 1 |
| Afrianti, R; Akbar, MR; Irvan, I; Martha, JW; Pranata, R; Wibowo, A | 1 |
| Akgüllü, Ç; Boyacıoğlu, M; Eryilmaz, U; Kum, C; Meteoğlu, I; Onbaşılı, OA; Saruhan, T | 1 |
| Akdemir, O; Ates, U; Cavusoğlu, T; Erbas, O; Karadeniz, M; Karadeniz, T; Tuglu, MI; Turkmen, E; Uyanıkgil, Y | 1 |
| Ben Abdennebi, H; Hadj Ayed Tka, K; Mahfoudh-Boussaid, A; Roselló-Catafau, J; Zaouali, MA | 1 |
| Annapureddy, N; Benjo, AM; Javed, F; Konstantinidis, I; Kumbala, D; Nadkarni, GN; Pakanati, KC; Patel, A; Patel, RA; Simoes, PK; Yacoub, R | 1 |
| Cen, XJ; Ding, YH; Huang, DS; Jin, QY; Qian, LY; Zhu, XX; Zou, H | 1 |
| Araujo, CR; De la Cruz Rodríguez, LC; Posleman, SE; Rey, MR | 1 |
| Ahmed, K; Ahsan, SA; Banerjee, SK; Bhuiyan, MM; Debnath, RC; Haque, SS; Joarder, AI; Mahmood, M; Rahman, F; Rahman, MM; Rokeya, B; Siddique, MA | 1 |
| Chopra, K; Satyanarayana, PS | 1 |
| Atik, U; Aytacoğlu, B; Bilgin, R; Coskun, B; Dikmengil, M; Ercan, B; Gul, A; Sucu, N; Tamer, L; Unlu, A | 1 |
| Chander, V; Chopra, K; Singh, D | 1 |
| Chopra, K; Singh, D | 1 |
| Chlubek, D; Ciechanowski, K; Domanski, L; Olszewska, M; Pawlik, A; Safranow, K; Sulikowski, T; Urasinska, E | 1 |
| Agaoglu, P; Akar, H; Discigil, G; Karul, A; Onbasili, AO; Tekten, T; Yeniceriglu, Y | 1 |
| Fung, JW; Szeto, CC; Yu, CM | 1 |
| Campi, S; Catapano, AL; Faggiotto, A; Redaelli, L; Zoppo, A | 1 |
4 review(s) available for trimetazidine and Kidney Diseases
| Article | Year |
|---|---|
Trimetazidine an emerging paradigm in renal therapeutics: Preclinical and clinical insights.
Topics: Animals; Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Kidney; Kidney Diseases; Oxidative Stress; Protective Agents; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2021 |
The effect of trimetazidine on contrast-induced nephropathy in patients undergoing coronary angiography and/or percutaneous coronary intervention - A systematic review and meta-analysis.
Topics: Contrast Media; Coronary Angiography; Humans; Kidney Diseases; Percutaneous Coronary Intervention; Trimetazidine | 2021 |
Trimetazidine Decreases Risk of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease: A Meta-Analysis of Randomized Controlled Trials.
Topics: Aged; Contrast Media; Female; Humans; Kidney Diseases; Male; Middle Aged; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Trimetazidine; Vasodilator Agents | 2015 |
Trimetazidine in conditions other than coronary disease, old drug, new tricks?
Topics: Acetyl-CoA C-Acyltransferase; Antineoplastic Agents; Chemically-Induced Disorders; Coronary Artery Disease; Diabetic Cardiomyopathies; Drug Repositioning; Humans; Kidney Diseases; Mitochondria, Heart; Trimetazidine; Vasodilator Agents | 2017 |
4 trial(s) available for trimetazidine and Kidney Diseases
| Article | Year |
|---|---|
Preventive effect of trimetazidine on contrast-induced nephropathy undergoing percutaneous coronary intervention in elderly moderate and high risk diabetics stratified by mehran score.
Topics: Aged; Contrast Media; Coronary Angiography; Creatinine; Diabetes Mellitus; Humans; Kidney Diseases; Percutaneous Coronary Intervention; Risk Factors; Trimetazidine | 2021 |
Trimetazidine can prevent the occurrence of contrast-induced nephropathy after percutaneous coronary intervention in elderly patients with renal insufficiency.
Topics: Acute Kidney Injury; Aged; Contrast Media; Coronary Angiography; Creatinine; Humans; Kidney Diseases; Percutaneous Coronary Intervention; Renal Insufficiency; Trimetazidine | 2021 |
Trimetazidine in the prevention of contrast induced nephropathy after coronary angiogram.
Topics: Adult; Aged; Contrast Media; Coronary Angiography; Creatinine; Female; Humans; Kidney Diseases; Male; Middle Aged; Sodium Chloride; Trimetazidine; Vasodilator Agents | 2012 |
Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures.
Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Cardiac Catheterization; Contrast Media; Coronary Angiography; Creatinine; Double-Blind Method; Female; Humans; Iohexol; Isotonic Solutions; Kidney Diseases; Male; Middle Aged; Premedication; Prospective Studies; Renal Insufficiency, Chronic; Sodium Chloride; Trimetazidine; Vasodilator Agents | 2007 |
14 other study(ies) available for trimetazidine and Kidney Diseases
| Article | Year |
|---|---|
Evaluating the protective role of trimetazidine versus nano-trimetazidine in amelioration of bilateral renal ischemia/reperfusion induced neuro-degeneration: Implications of ERK1/2, JNK and Galectin-3 /NF-κB/TNF-α/HMGB-1 signaling.
Topics: Caspase 3; Galectin 3; HMGB Proteins; Humans; Ischemia; Kidney Diseases; MAP Kinase Signaling System; NF-kappa B; Reperfusion; Reperfusion Injury; Trimetazidine; Tumor Necrosis Factor-alpha | 2023 |
The effect of trimetazidine on preventing contrast-induced nephropathy after cardiac catheterization.
Topics: Aged; Cardiac Catheterization; Contrast Media; Female; Humans; Kidney Diseases; Male; Middle Aged; Percutaneous Coronary Intervention; Prospective Studies; Trimetazidine | 2019 |
Trimetazidine Protects from Mercury-Induced Kidney Injury.
Topics: Animals; Creatinine; Dicarboxylic Acid Transporters; Glutathione; Glycosuria; Kidney Diseases; Lipid Peroxidation; Male; Malondialdehyde; Mercuric Chloride; Mercury Poisoning; Organic Anion Transporters, Sodium-Dependent; Oxidative Stress; Protective Agents; Rats, Wistar; Sodium Chloride; Symporters; Trimetazidine; Urea; Urination | 2021 |
The first histopathological evidence of trimetazidine for the prevention of contrast-induced nephropathy.
Topics: Animals; Antioxidants; Body Weight; Catalase; Contrast Media; Creatinine; Glutathione; Kidney; Kidney Diseases; Male; Malondialdehyde; Organ Size; Rats, Wistar; Superoxide Dismutase; Trimetazidine | 2014 |
Experimental comparison of protective characteristics of enalapril and trimetazidine in diabetic nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enalapril; Kidney Diseases; Male; Rats; Rats, Sprague-Dawley; Trimetazidine | 2014 |
Effects of trimetazidine on the Akt/eNOS signaling pathway and oxidative stress in an in vivo rat model of renal ischemia-reperfusion.
Topics: Animals; Blotting, Western; Heme Oxygenase-1; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney Diseases; Male; Nitric Oxide Synthase Type III; Oxidative Stress; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Reperfusion Injury; Signal Transduction; Trimetazidine; Vasodilator Agents | 2014 |
Attenuation of gentamicin-induced nephrotoxicity: trimetazidine versus N-acetyl cysteine.
Topics: Acetylcysteine; Acetylglucosaminidase; Animals; Biomarkers; Creatinine; Free Radical Scavengers; gamma-Glutamyltransferase; Gentamicins; Kidney Cortex; Kidney Diseases; Male; Nephrons; Rats; Rats, Wistar; Trimetazidine | 2010 |
Oxidative stress-mediated renal dysfunction by cyclosporine A in rats: attenuation by trimetazidine.
Topics: Animals; Biomarkers; Blood Pressure; Blood Urea Nitrogen; Body Weight; Creatinine; Cyclosporine; Disease Models, Animal; Drinking; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Immunosuppressive Agents; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Oxidative Stress; Rats; Rats, Wistar; Systole; Thiobarbituric Acid Reactive Substances; Time Factors; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2002 |
Effects of trimetazidine on tissue damage in kidney after hindlimb ischemia-reperfusion.
Topics: Animals; Glutathione; Hindlimb; Kidney Diseases; Male; Malondialdehyde; Oxidation-Reduction; Peroxidase; Rats; Rats, Wistar; Regional Blood Flow; Reperfusion Injury; Sodium-Potassium-Exchanging ATPase; Superoxide Dismutase; Trimetazidine; Vasodilator Agents | 2002 |
Carvedilol and trimetazidine attenuates ferric nitrilotriacetate-induced oxidative renal injury in rats.
Topics: Animals; Antioxidants; Blood Urea Nitrogen; Carbazoles; Carcinogens; Carvedilol; Catalase; Creatinine; Drug Interactions; Ferric Compounds; Glutathione; Glutathione Reductase; Histocytochemistry; Kidney Diseases; Lipid Peroxidation; Male; Nitrilotriacetic Acid; Oxidative Stress; Propanolamines; Rats; Rats, Wistar; Superoxide Dismutase; Trimetazidine | 2003 |
Effect of trimetazidine on renal ischemia/reperfusion injury in rats.
Topics: Animals; Kidney; Kidney Diseases; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Trimetazidine | 2004 |
Effect of trimetazidine on the nucleotide profile in rat kidney with ischemia-reperfusion injury.
Topics: Adenine Nucleotides; Animals; Antioxidants; Disease Models, Animal; Graft Rejection; Kidney Cortex Necrosis; Kidney Diseases; Kidney Tubules; Male; Organ Preservation; Rats; Rats, Wistar; Reperfusion Injury; Trimetazidine | 2006 |
Preventing contrast nephropathy in catheter laboratory.
Topics: Acetylcysteine; Angioplasty, Balloon, Coronary; Cardiac Catheterization; Contrast Media; Coronary Angiography; Hemofiltration; Humans; Kidney; Kidney Diseases; Trimetazidine; Vasodilator Agents | 2007 |
Trimetazidine counteracts tacrolimus nephrotoxicity in a hypertensive liver transplant patient.
Topics: Humans; Hypertension; Immunosuppressive Agents; Kidney Diseases; Liver Cirrhosis; Liver Transplantation; Tacrolimus; Trimetazidine; Vasodilator Agents | 1999 |